Immunovia announced that the company has successfully developed accurate and precise assays to measure targeted proteins for its next-generation test. As announced in November 2023, Immunovia.
Immunovia AB: Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Immunovia (NASDAQ: IMMNOV) (STO: IMMNOV), the diagnostics company with the mission to increase pancreatic cancer survival rates through early.
Immunovia AB: Immunovia Publishes Full Year Report for 2023 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.